These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2005-005792-15||Evaluation of the efficacy of topical formulations containing ASF-1075 in the prevention and treatment of contact dermatitis||2006-06-23||due-trials|
|Not reported||2005-005793-75||Evaluation of the efficacy of a topical formulation containing ASF-1075 in the treatment of chronic hand dermatitis||2007-06-07||due-trials|
|Listed as ongoing, but also has a completion date||2006-001062-17||Efficacy and safety of ASF-1096 Cream 0.5% in the treatment of patients with newly developed discoid lupus erythematosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and double ...||2007-07-27||bad-data|
|Not reported||2006-001186-42||Determination of antipsoriatic efficacy of topical formulations in a psoriasis plaque test||2006-08-28||due-trials|
|Completed, but no date||2006-003780-30||Efficacy and safety of ASF-1096 cream 0.5 % in the treatment of patients with newly developed discoid lupus erythematosus (DLE) lesions. A multi-centre clinical phase 2, placebo controlled and double ...||bad-data|
|Completed, but no date Terminated||2006-005221-37||Efficacy and safety of ASF-1075 cream 2.5% and 5% on pruritus in patients with lichen simplex chronicus (neurodermatitis) of the anogenital region. A phase II, multi-centre, double-blind, vehicle-cont...||bad-data|
|Not reported||2006-005637-37||Comparative, placebo controlled, double-blind efficacy and safety study in patients with seborrhoeic dermatitis comparing a topical cream containing 2% Nicotinamide combined with either 0%, 0.5% or 1....||2007-05-24||due-trials|
|Other||2007-003212-65||Efficacy and safety of ASF-1075 cream 5% on pruritus in adult patients with atopic dermatitis. A multi-centre, randomised, double-blind, vehicle-controlled, parallel groups, proof of concept study.||not-yet-due|
|Listed as ongoing, but also has a completion date||2007-004627-38||Efficacy and safety of ASF 1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, double-blind, vehicle- and placebo controlled, parallel groups, multi-centre trial||2008-05-15||bad-data|
|Ongoing||2007-004635-29||Estudio aleatorizado, controlado con placebo, internacional, multicéntrico, doble ciego, de confirmación de dosis, para evaluar la seguridad y la eficacia de la crema ASF-1096 0,25%, 0,5% y 1% y place...||not-yet-due|
|Not reported Terminated||2007-004648-54||Efficacy and safety of ASF-1057 cream 0.5% in the treatment of seborrhoeic dermatitis: A phase III randomised, multi-centre, double-blind, active comparator (ketoconazole cream 2%) and placebo control...||2008-05-15||due-trials|
|Ongoing||2007-004649-14||Safety of ASF 1057 cream 0.5% under long term use in the treatment of seborrhoeic dermatitis: A 12 month open label extension multi-centre phase III trial||not-yet-due|